De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Orion Oyj Beheer
Beheer criteriumcontroles 2/4
De CEO Orion Oyj's is Liisa Hurme, benoemd in Jan2019, heeft een ambtstermijn van 5.75 jaar. De totale jaarlijkse vergoeding van { bedraagt € 819.50K, bestaande uit 81.6% salaris en 18.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.023% van de aandelen van het bedrijf, ter waarde € 1.57M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.9 jaar en 4.4 jaar.
Belangrijke informatie
Liisa Hurme
Algemeen directeur
€819.5k
Totale compensatie
| Percentage CEO-salaris | 81.6% |
| Dienstverband CEO | 5.8yrs |
| Eigendom CEO | 0.02% |
| Management gemiddelde ambtstermijn | 1.9yrs |
| Gemiddelde ambtstermijn bestuur | 4.4yrs |
Recente managementupdates
Recent updates
Orion Oyj's (HEL:ORNBV) Shareholders Might Be Looking For Exit
Sep 25
Orion Oyj (HEL:ORNBV) Has A Pretty Healthy Balance Sheet
Sep 02Orion Oyj Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
Aug 12Are Investors Undervaluing Orion Oyj (HEL:ORNBV) By 42%?
Jul 14Orion Oyj's (HEL:ORNBV) Shares May Have Run Too Fast Too Soon
Jun 17Here's Why Orion Oyj (HEL:ORNBV) Can Manage Its Debt Responsibly
May 27We Think That There Are More Issues For Orion Oyj (HEL:ORNBV) Than Just Sluggish Earnings
May 05Orion Oyj Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Apr 27Earnings Beat: Orion Oyj Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 16Why Investors Shouldn't Be Surprised By Orion Oyj's (HEL:ORNBV) P/E
Feb 01Orion Oyj (HEL:ORNBV) Has A Pretty Healthy Balance Sheet
Jan 11Are Investors Undervaluing Orion Oyj (HEL:ORNBV) By 43%?
Nov 28We Think That There Are More Issues For Orion Oyj (HEL:ORNBV) Than Just Sluggish Earnings
Nov 03Orion Oyj (HEL:ORNBV) Could Easily Take On More Debt
Oct 05Orion Oyj's (HEL:ORNBV) Intrinsic Value Is Potentially 51% Above Its Share Price
Aug 18Is Orion Oyj (HEL:ORNBV) Using Too Much Debt?
Jun 21A Look At The Intrinsic Value Of Orion Oyj (HEL:ORNBV)
May 16Here's Why We Think Orion Oyj (HEL:ORNBV) Is Well Worth Watching
Apr 07Orion Oyj (HEL:ORNBV) Could Easily Take On More Debt
Mar 20Orion Oyj's (HEL:ORNBV) Upcoming Dividend Will Be Larger Than Last Year's
Feb 12A Look At The Intrinsic Value Of Orion Oyj (HEL:ORNBV)
Feb 07Is Orion Oyj (HEL:ORNBV) Trading At A 29% Discount?
Oct 13Orion Oyj (HEL:ORNBV) Seems To Use Debt Quite Sensibly
Sep 22This Just In: Analysts Are Boosting Their Orion Oyj (HEL:ORNBV) Outlook for This Year
Jul 21Is There An Opportunity With Orion Oyj's (HEL:ORNBV) 34% Undervaluation?
Jul 10Does Orion Oyj (HEL:ORNBV) Have A Healthy Balance Sheet?
Jun 14Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €232m |
| Mar 31 2024 | n/a | n/a | €217m |
| Dec 31 2023 | €820k | €668k | €217m |
| Sep 30 2023 | n/a | n/a | €173m |
| Jun 30 2023 | n/a | n/a | €306m |
| Mar 31 2023 | n/a | n/a | €336m |
| Dec 31 2022 | €106k | €106k | €350m |
Compensatie versus markt: De totale vergoeding ($USD 903.93K ) Liisa } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Finnish markt ($USD 1.23M ).
Compensatie versus inkomsten: De beloning van Liisa is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Liisa Hurme (57 yo)
5.8yrs
Tenure
€819,500
Compensatie
Dr. Liisa Hurme, PhD (Biochemistry), has been President , Chief Executive Officer and Chairman of Managemenbt board at Orion Oyj since Novemnber 01, 2022. Dr. Hurme served as Senior Vice President, Global...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 5.8yrs | €819.50k | 0.023% € 1.5m | |
| Chief Financial Officer & Member of Group Executive Management Board | less than a year | geen gegevens | geen gegevens | |
| Senior VP of Corporate Functions | 22yrs | geen gegevens | 0.060% € 4.0m | |
| Senior VP of Generics and Consumer Health Business Division & Member of the Exe. Mgmt. Board | 16.8yrs | geen gegevens | 0.025% € 1.6m | |
| Sr. VP of Innovative Medicines | 4.3yrs | geen gegevens | 0.010% € 683.5k | |
| Senior VP of Global Operations & Member of Executive Management Board | 1.9yrs | geen gegevens | 0.0036% € 238.5k | |
| Senior VP of Animal Health Business Division & Member of the Exe. Mgmt. Board | 1.8yrs | geen gegevens | 0.0031% € 204.4k | |
| Senior VP of the Branded Products Business Division & Member of the Exe. Mgmt. Board | 1.8yrs | geen gegevens | 0.010% € 695.5k | |
| Senior Vice President of People & Culture and Member of Management Board | less than a year | geen gegevens | geen gegevens | |
| Investor Relations & Financial Communications Officer | no data | geen gegevens | geen gegevens | |
| Vice President of Communications | 15.5yrs | geen gegevens | geen gegevens | |
| Sr. VP of Corporate Strategy and Program Mgmt. Grp. Level Function & Head of CSPMO | less than a year | geen gegevens | 0.023% € 1.5m |
1.9yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ORNBV wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Independent Director | 10.6yrs | €123.40k | 0.0069% € 463.0k | |
| Independent Chairman | 3.6yrs | €61.40k | 0.0066% € 441.0k | |
| Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 4.4yrs | €61.40k | 0.062% € 4.2m | |
| Independent Director | 7.6yrs | €72.40k | 0.0036% € 242.5k | |
| Independent Director | 2.6yrs | €60.80k | 0.0011% € 72.2k | |
| Independent Director | 8.6yrs | €61.40k | 0.41% € 27.4m | |
| Independent Vice Chairman of the Board | 7.6yrs | €81.10k | 0.0073% € 485.7k | |
| Independent Director | 2.6yrs | €66.80k | 0.0011% € 72.2k |
4.4yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ORNBV wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).